These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21122674)

  • 21. Diagnosing familial hypercholesterolaemia: the relevance of genetic testing.
    van Aalst-Cohen ES; Jansen AC; Tanck MW; Defesche JC; Trip MD; Lansberg PJ; Stalenhoef AF; Kastelein JJ
    Eur Heart J; 2006 Sep; 27(18):2240-6. PubMed ID: 16825289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric implications of heterozygous familial hypercholesterolemia. Screening and dietary treatment.
    Kwiterovich PO
    Arteriosclerosis; 1989; 9(1 Suppl):I111-20. PubMed ID: 2563219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is there a need for genetic/molecular diagnosis of familial hypercholesterolemia?].
    Leren TP; Ose L
    Tidsskr Nor Laegeforen; 1997 Feb; 117(5):681-3. PubMed ID: 9102961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients' attitudes toward detection of heterozygous familial hypercholesterolemia.
    Andersen LK; Jensen HK; Juul S; Faergeman O
    Arch Intern Med; 1997 Mar; 157(5):553-60. PubMed ID: 9066460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular genetic analysis of 1053 Danish individuals with clinical signs of familial hypercholesterolemia.
    Brusgaard K; Jordan P; Hansen H; Hansen AB; Hørder M
    Clin Genet; 2006 Mar; 69(3):277-83. PubMed ID: 16542394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cascade genetic screening for familial hypercholesterolemia.
    Leren TP
    Clin Genet; 2004 Dec; 66(6):483-7. PubMed ID: 15521974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland.
    Koivisto UM; Turtola H; Aalto-Setälä K; Top B; Frants RR; Kovanen PT; Syvänen AC; Kontula K
    J Clin Invest; 1992 Jul; 90(1):219-28. PubMed ID: 1634609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Familial hypercholesterolemia and plasma Lp(a) levels: 2 cardiovascular risk factors].
    Real JT; Romero G; Priego MA; Chaves FJ; Ascaso JF; Carmena R
    An Med Interna; 1999 Feb; 16(2):69-72. PubMed ID: 10192997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA diagnosis of familial hypercholesterolemia.
    Schuster H
    Eur J Med Res; 1998 Feb; 3(1-2):42-4. PubMed ID: 9512966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
    Fouchier SW; Kastelein JJ; Defesche JC
    Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NLA Symposium screening and treatment of familial hypercholesterolemia: how can we do better? Opening and introductions.
    McGowan M
    J Clin Lipidol; 2010; 4(5):335-7. PubMed ID: 21122673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred.
    Takada D; Emi M; Ezura Y; Nobe Y; Kawamura K; Iino Y; Katayama Y; Xin Y; Wu LL; Larringa-Shum S; Stephenson SH; Hunt SC; Hopkins PN
    J Hum Genet; 2002; 47(12):656-64. PubMed ID: 12522687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric measurement of low density lipoprotein receptor activity validated by DNA analysis in diagnosing heterozygous familial hypercholesterolemia.
    Urdal P; Leren TP; Tonstad S; Lund PK; Ose L
    Cytometry; 1997 Oct; 30(5):264-8. PubMed ID: 9383100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic tests for familial hypercholesterolemia.
    Day I; Humphries S
    Nat Biotechnol; 1996 Oct; 14(10):1227-8. PubMed ID: 9631083
    [No Abstract]   [Full Text] [Related]  

  • 37. [Application of gene technology in the diagnosis of familial hypercholesterolemia].
    Leren TP; Bakken KS; Rødningen OK; Gundersen KE; Sundvold H; Berg K; Tonstad S; Ose L
    Tidsskr Nor Laegeforen; 1997 Feb; 117(5):678-81. PubMed ID: 9102960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial hypercholesterolemia mutations in the Middle Eastern and North African region: a need for a national registry.
    Bamimore MA; Zaid A; Banerjee Y; Al-Sarraf A; Abifadel M; Seidah NG; Al-Waili K; Al-Rasadi K; Awan Z
    J Clin Lipidol; 2015; 9(2):187-94. PubMed ID: 25911074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of people with heterozygous familial hypercholesterolemia.
    Haase A; Goldberg AC
    Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia.
    Langslet G; Ose L
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1061-6. PubMed ID: 23984929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.